HEPA - Hepion Pharmaceuticals, Inc.
0.3239
0.026 8.151%
Share volume: 3,434,888
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.30
0.03
0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-21-2024 | 08-13-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 5.182 M | 8.504 M | 4.458 M | |
| Selling general and admin | 2.643 M | 1.367 M | 1.696 M | |
| Research and development | 2.540 M | 7.137 M | 2.763 M | |
| Total expenses | 5.182 M | 8.504 M | 4.458 M | |
| 64.09% | -47.57% | |||
| Operating income | -5.182 M | -8.504 M | -4.458 M | |
| Ebit | 0.000 | 0.000 | 0.000 | |
| Pretax income | -5.823 M | -3.925 M | -4.866 M | |
| -32.59% | 23.97% | |||
| Income tax | -2.969 M | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -2.854 M | -3.925 M | -4.866 M | |
| -37.54% | -23.97% |
